Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medtronic (NY: MDT )

86.21 +1.47 (+1.73%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
5 Dividend Growth Stocks to Buy and Hold Forever
Dividend growth stocks offer investors a powerful combination of income and capital appreciation potential, making them attractive for long-term portfolios. 
Via The Motley Fool
3 Dividend Stocks to Double Up On Right Now
How does a 5.7% dividend yield sound? 
Via The Motley Fool
Robinhood To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
7 Defensive Stocks to Buy as Investors Seek Shelter
With the market primed for more jitters, investors should consider battening down the hatches with these defensive stocks. 
Via InvestorPlace
TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Key Takeaways From Medtronic Analyst Ratings
Via Benzinga
Looking Into Medtronic's Recent Short Interest
Via Benzinga
Why NYSE:MDT qualifies as a good dividend investing stock.
Balancing Dividends and Fundamentals: The Case of MEDTRONIC PLC (NYSE:MDT). 
Via Chartmill
Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?
Surgical robotics company PROCEPT BioRobotics Co. (NASDAQ: PRCT) developed the AquaBeam Robotic System for the treatment of benign prostatic hyperplasia 
Via MarketBeat
Abbott Laboratories Stock Could Soar to $143, According to a Wall Street Analyst. Is It a Buy Around $108?
An unexpected diabetes partnership with Medtronic bodes well for Abbott's biggest growth driver. 
Via The Motley Fool
Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
Chips, Glorious Chips!
Someone's gotta make 'em, and someone's gotta buy 'em. 
Via The Motley Fool
Top Dividend Aristocrat Picks In July 2024
The following 3 dividend stocks have increased payouts for over 25 consecutive years. 
Via Talk Markets
What 8 Analyst Ratings Have To Say About Medtronic
Via Benzinga
Medical Technology Stock Benefits from Rising Acute Care Demand
Medical and surgical products manufacturer Stryker Co. (NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry. 
Via MarketBeat
Topics Supply Chain
Exposures Supply Chain
Why Intuitive Surgical Stock is Dominating the Medical Sector
Robotic surgery conjures up futuristic images of automated machines performing surgery on anesthetized human patients in an assembly line. However 
Via MarketBeat
2 Dividend Stocks to Buy and Never Sell
These two are rock-solid businesses with strong dividend programs. 
Via The Motley Fool
As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott
Dexcom is taking on bigger rival Abbott Laboratories with a continuous glucose monitor for non insulin users. 
Via Investor's Business Daily
3 AI-Powered Healthcare Stocks Transforming Medicine
Invest in AI healthcare stocks to benefit significantly from tech that could propel the healthcare market to $148.4 billion by 2029. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 AI-in-Healthcare Stocks to Buy for Outsized Returns
These are the AI healthcare stocks to buy as they represent medical technology investing in research and development for accelerated growth. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Blue-Chip Stocks to Buy for the Second Half of 2024
Despite recent scrutiny, blue-chip stocks offer a chance to capitalize on market lulls and a sector snapback 
Via InvestorPlace
7 Blue-Chip Stocks to Buy on the Dip: July 2024
Buy high-quality at relative bargain prices, if you decide to take advantage of recent weakness with these seven blue-chip stocks. 
Via InvestorPlace
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
Abbott Laboratories is launching Lingo, an over-the-counter glucose monitoring device aimed at non-diabetic consumers, utilizing TV and guerilla marketing. CEO Robert Ford expects Lingo to become a... 
Via Benzinga
If You Can Only Buy One Robotics Stock in July, It Better Be One of These 3 Names
These three robotics stocks look well-positioned to ride strong secular tailwinds higher, despite most investors attention being on AI today. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Dividend Stocks That Demand Investor Attention
Explore and consider three heavyweight dividend stocks that offer strong yields and growth potential for savvy investors. 
Via InvestorPlace
3 Neurotech Stocks Bridging Mind and Machine
These neurotech stocks stand at the cutting edge of healthcare, but early entrants in new fields tend to be long-term winners. 
Via InvestorPlace
3 Robotics Stocks That Could Be Multibaggers in the Making: July Edition
Explore robotics stocks with significant growth potential as the industry advances and integrates into various sectors. 
Via InvestorPlace
3 Robotics Stocks to Buy Now: Q3 Edition
Discover key robotics stocks to buy now for Q3. Learn about industry leaders in autonomous vehicles, robotic surgery and IoT integration. 
Via InvestorPlace
7 ‘Death Cross’ Stocks That Could Be Contrarian Buys
Although death cross stocks sound incredibly ominous, they could be the ideal time to consider a contrarian position. 
Via InvestorPlace
7 High-Yield Dividend Stocks Beating Inflation
High-yield dividend stocks are one of the surest paths to beating inflation as the cost of everything remains high in mid-2024. 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.